Arvin BioHealth (ABH) as a knowledge-based enterprise was established in 2015 under the Arvin Pazoohan Noor (APN) holding group with the efforts of faculty university members and research centers due to the world’s needs in the field of vaccines and medical diagnostic kits.
This company has started its activities in the fields of research, development, production, and distribution of medical diagnostic products, including rapid diagnostic tests, enzyme-linked immunosorbent assay (ELISA),
The main goals of this collection:
Improving the quality of manufactured products /Development of scientific ability/ Research and localization of today’s technology in the fields of biology, medicine, veterinary medicine and agriculture in order to create a healthy society.
Arvin Bio Health Company provides infrastructure such as advanced machines, clean rooms, experienced technical force and implementation of quality management system for medical products based on the requirements of EN: ISO 13485:2016 and is always trying to provide accurate diagnostic tools. To provide trust, easy, affordable and suitable for users and the environment to the public. These products can be widely used in hospitals, clinical laboratories, doctors’ offices, veterinary clinics and home use for screening, prognosis, diagnosis and treatment monitoring.
In order to make it easier for you to know the products better, your frequently asked questions have been answered briefly. If you need more explanation, contact our professionals
No. This kit detects the antigen of the virus from the second to the seventh day after infection, so a negative result does not rule out the possibility of contamination or infection. also, the type of sampling is very effective in the results.
No. The positive result of this test only shows that your body’s immune system has already encountered this virus and does not indicate the development or lack of immunity.
Introduction of the knowledge-based Arvin BioHealth company in the Khabar Network’s noavaran program
In this report, the activities and services of the knowledge-based Arvin BioHealth company, one of the subgroups of Arvin Pazhoohan Noor Holding, are depicted in the words of the company's managers and experts Mr .Dr Hasan Morovati Khamsi In this program, as the founder and managing director of knowledge-based Arvin BioHealth, while briefly introducing the company's activities and products of the rapid diagnosis kits during the difficult times of the Corona epidemic, which played a significant role in the rapid diagnosis of diseases in the country, they expressed hope that with More and better support of knowledge-based companies and manufacturers in the country's health field by the government , Arvin BioHealth can offer a more diverse and better portfolio of products in the domestic and Middle Eastern markets, and while preventing foreign exchange from leaving the country, it will increase health in become a country
Mr. Dr. Shujaei, production manager, Ms. Dr. Ahmadi, responsible, Mr. Soharri, Ms. Zare, Ms. Tavasuli and Ms. Sadeqpour, as experts in quality assurance and research and development of the production department of Arvin BioHealth, also explained in this report about the types of products of the company in now and in the future, they presented the role and activities of different units in the growth and advancement of the company's goals, as well as receiving international ISOs.
The innovators program introduces active knowledge-based companies in the field of health.
Read the most comprehensive and up-to-date medical and therapeutic articles and events here
in December 2019, a large outbreak of the novel coronavirus disease (COVID–19) occurred in Wuhan, China, and rapidly spread to other countries. This new class
Acute respiratory syndrome coronavirus (SARS-CoV-2) 2 is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and caused an acute respiratory disease pandemic
All coagulation factors are synthesized by the liver except for factor VIII, which is produced by endothelial cells. VWF is also synthesized in megakaryocytes in
Read the latest and most recent medical and therapeutic news and events here
